Sanara MedTech Inc. (SMTI)
Sanara MedTech Statistics
Share Statistics
Sanara MedTech has 8.89M shares outstanding. The number of shares has increased by 3.21% in one year.
| Shares Outstanding | 8.89M |
| Shares Change (YoY) | 3.21% |
| Shares Change (QoQ) | 1.84% |
| Owned by Institutions (%) | 11.19% |
| Shares Floating | 2.98M |
| Failed to Deliver (FTD) Shares | 210 |
| FTD / Avg. Volume | 0.87% |
Short Selling Information
The latest short interest is 180.35K, so 2.03% of the outstanding shares have been sold short.
| Short Interest | 180.35K |
| Short % of Shares Out | 2.03% |
| Short % of Float | 4.36% |
| Short Ratio (days to cover) | 4.13 |
Valuation Ratios
The PE ratio is -29.15 and the forward PE ratio is -13.27. Sanara MedTech's PEG ratio is -0.24.
| PE Ratio | -29.15 |
| Forward PE | -13.27 |
| PS Ratio | 3.25 |
| Forward PS | 2.6 |
| PB Ratio | 7.15 |
| P/FCF Ratio | -1226.64 |
| PEG Ratio | -0.24 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Sanara MedTech.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.18, with a Debt / Equity ratio of 0.04.
| Current Ratio | 2.18 |
| Quick Ratio | 2 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | -0.86 |
| Debt / FCF | -6.95 |
| Interest Coverage | -2.15 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $614.7K |
| Profits Per Employee | $-68.54K |
| Employee Count | 141 |
| Asset Turnover | 0.98 |
| Inventory Turnover | 2.96 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by 3.51% in the last 52 weeks. The beta is 1.47, so Sanara MedTech's price volatility has been higher than the market average.
| Beta | 1.47 |
| 52-Week Price Change | 3.51% |
| 50-Day Moving Average | 31.61 |
| 200-Day Moving Average | 32.91 |
| Relative Strength Index (RSI) | 57.18 |
| Average Volume (20 Days) | 24.27K |
Income Statement
In the last 12 months, Sanara MedTech had revenue of 86.67M and earned -9.66M in profits. Earnings per share was -1.14.
| Revenue | 86.67M |
| Gross Profit | 78.53M |
| Operating Income | -6.72M |
| Net Income | -9.66M |
| EBITDA | -1.86M |
| EBIT | -6.78M |
| Earnings Per Share (EPS) | -1.14 |
Balance Sheet
The company has 15.88M in cash and 1.6M in debt, giving a net cash position of 14.28M.
| Cash & Cash Equivalents | 15.88M |
| Total Debt | 1.6M |
| Net Cash | 14.28M |
| Retained Earnings | -37.78M |
| Total Assets | 88.09M |
| Working Capital | 17.27M |
Cash Flow
In the last 12 months, operating cash flow was -23.78K and capital expenditures -205.85K, giving a free cash flow of -229.63K.
| Operating Cash Flow | -23.78K |
| Capital Expenditures | -205.85K |
| Free Cash Flow | -229.63K |
| FCF Per Share | -0.03 |
Margins
Gross margin is 90.61%, with operating and profit margins of -7.75% and -11.15%.
| Gross Margin | 90.61% |
| Operating Margin | -7.75% |
| Pretax Margin | -11.15% |
| Profit Margin | -11.15% |
| EBITDA Margin | -2.15% |
| EBIT Margin | -7.75% |
| FCF Margin | -0.26% |
Dividends & Yields
SMTI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for SMTI is $48.5, which is 51.1% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $48.5 |
| Price Target Difference | 51.1% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
Stock Splits
The last stock split was on May 10, 2019. It was a backward split with a ratio of 1:100.
| Last Split Date | May 10, 2019 |
| Split Type | backward |
| Split Ratio | 1:100 |
Scores
| Altman Z-Score | 3.8 |
| Piotroski F-Score | 6 |